Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07791576 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Population PK-guided ATG Dosing in Haplo-HSCT

Name: Population PK-guided ATG Dosing in Haplo-HSCT — clinical trial record (NCT07791576)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusRecruiting

PhasePhase 2

SponsorChinese PLA General Hospital

Started2025-05-10

View on ClinicalTrials.gov ↗

Chinese PLA General Hospital

193 trials monitored

See 4 trials at risk

To evaluate the safety and efficacy of a population pharmacokinetics (PK)-guided targeted ATG dosing strategy in haploidentical stem cell transplantation and to observe the GVHD-free, relapse-free survival (GRFS) in the cohort receiving this strategy.

Trial Details

NCT Number	NCT07791576
Lead Sponsor	Chinese PLA General Hospital
Conditions	Hematopoietic Stem Cell Transplantation
Enrollment	63 participants
Start Date	2025-05-10
Primary Completion	2026-12-30 (estimated)
Study Completion	2027-12-30 (estimated)
Updated on ClinicalTrials.gov	2026-08-28